Trial intelligence / Profile preview

Trospium Chloride XR in Obese Female Patients With OAB

NCT00932022Phase 4Completed

Sponsor
Allergan
Start
Jul 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of trospium in overactive bladder (OAB), sponsored by Allergan. Started Jul 2009; status: completed.

02

Drugs

trospium
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on NCT00932022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00932022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call